Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Doyle

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
BMC Psychiatry|September 18, 2007
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric O Mick, Craig Surman, et al.
CNS Spectrums|April 28, 2006
An open-label trial of OROS methylphenidate in adults with late-onset ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Clinical Psychopharmacology|January 17, 2007
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patientsMargherita Dalessandro, Chiara M Conti, Francesco Gambi, et al.
The Journal of Pediatrics|August 11, 2012
Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidatePaul Hammerness, Gagan Joshi, Robert Doyle, et al.
Biological Psychiatry|December 24, 2005
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric Mick, Craig Surman, et al.
Biological Psychiatry|March 2, 2005
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderThomas Spencer, Joseph Biederman, Timothy Wilens, et al.
Human Psychopharmacology|January 16, 2007
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patientsEmanuela Tumini, Elisa Porcellini, Martina Chiappelli, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 23, 2012
A pilot open label prospective study of memantine monotherapy in adults with ADHDCraig B H Surman, Paul G Hammerness, Carter Petty, et al.
Journal of Attention Disorders|May 25, 2010
A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidateThomas J Spencer, Eric Mick, Craig B H Surman, et al.
Journal of Child and Adolescent Psychopharmacology|February 20, 2010
A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorderGagan Joshi, Janet Wozniak, Eric Mick, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
BMC Psychiatry|September 18, 2007
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric O Mick, Craig Surman, et al.
CNS Spectrums|April 28, 2006
An open-label trial of OROS methylphenidate in adults with late-onset ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Clinical Psychopharmacology|January 17, 2007
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patientsMargherita Dalessandro, Chiara M Conti, Francesco Gambi, et al.
The Journal of Pediatrics|August 11, 2012
Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidatePaul Hammerness, Gagan Joshi, Robert Doyle, et al.
Biological Psychiatry|December 24, 2005
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric Mick, Craig Surman, et al.
Biological Psychiatry|March 2, 2005
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderThomas Spencer, Joseph Biederman, Timothy Wilens, et al.
Human Psychopharmacology|January 16, 2007
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patientsEmanuela Tumini, Elisa Porcellini, Martina Chiappelli, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 23, 2012
A pilot open label prospective study of memantine monotherapy in adults with ADHDCraig B H Surman, Paul G Hammerness, Carter Petty, et al.
Journal of Attention Disorders|May 25, 2010
A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidateThomas J Spencer, Eric Mick, Craig B H Surman, et al.
Journal of Child and Adolescent Psychopharmacology|February 20, 2010
A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorderGagan Joshi, Janet Wozniak, Eric Mick, et al.
Pageof 5